N-(4-Phenoxyphenyl)benzo[d]thiazol-2-amine

Catalog No. :
ACAZHQ479
CAS No. :
380346-15-6
Molecular Formula :
C19H14N2OS
Molecular Weight :
318.40

IUPAC Name:N-(4-phenoxyphenyl)benzo[d]thiazol-2-amine

N-(4-Phenoxyphenyl)benzo[d]thiazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$117.00Login to see priceInquiryInquiry
250mg95%$147.00Login to see priceInquiryInquiry
1g95%$381.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-Phenoxyphenyl)benzo[d]thiazol-2-amine
IUPAC NameN-(4-phenoxyphenyl)benzo[d]thiazol-2-amine
MDL No.MFCD02725637
Molecular FormulaC19H14N2OS
Molecular Weight318.40
SMILESC1(NC2=CC=C(OC3=CC=CC=C3)C=C2)=NC4=CC=CC=C4S1
InChI KeyKOOXDKCPRBHTHS-UHFFFAOYSA-N
SynonymN-(4-phenoxyphenyl)-1,3-benzothiazol-2-amine;2-Benzothiazolamine, N-(4-phenoxyphenyl)-;N-(4-Phenoxyphenyl)benzo[d]thiazol-2-amine
CAS No.380346-15-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACAZHQ479 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYICG726 route compound structure diagram
    ACYICG7262974-94-9 In Stock
  2. Plus
  3. ACLZNR081 route compound structure diagram
    ACLZNR08194787-08-3 In Stock
  4. Then
  5. ACAZHQ479 route product structure diagram
    ACAZHQ479380346-15-6
Inquiry

2. ACAZHQ479 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMFGI745 route compound structure diagram
    ACMFGI745139-59-3 In Stock
  2. Plus
  3. ACMYBS910 route compound structure diagram
    ACMYBS910934-34-9 In Stock
  4. Then
  5. ACAZHQ479 route product structure diagram
    ACAZHQ479380346-15-6
Inquiry

Comments (0)